Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-08-04
1997-03-18
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 5, 552502, A61K 31705
Patent
active
056123175
ABSTRACT:
The present invention relates to methods for the treatment or prevention of osteoporosis and the alleviation of the symptoms of menopause by the administration of an estrogen glycoside or estrogen orthoester glycoside.
REFERENCES:
patent: 4078060 (1978-03-01), Benson et al.
patent: 4096254 (1978-06-01), Benson et al.
patent: 4225596 (1980-09-01), DeLuca
patent: 4410515 (1983-10-01), Holick et al.
patent: 4521410 (1985-06-01), Holick et al.
patent: 5183814 (1993-02-01), Dukes
Conrow & Bernstein, "Steroid Conjugates. VI. An Improved Koenigs-Knorr Synthesis of Aryl Glucuronides Using Cadmium Carbonate, a New and Effective Catalyst," J. Org. Chem. 36:863-870 (Apr. 9, 1971).
Fujimoto et al., "Characterization of 17.beta.-estradiol 3-(.beta.-D-glucopyranoside) and 17-(.alpha.-D-glucopyransoside) as the metabolites of 17.beta.-estradiol in the cultured ovaries of the silkworm, Bombyx mori, " Experientia 42:567-568 (1986).
Hobkirk et al., "Metabolism of Intravenously Administered 17.beta.-Estradiol-6,7-H-3-glucoside-C in Normal Women," J. Clin. Endocrinol. 32:476-480 (Apr. 1971).
Williamson et al., "Isolation of 17.alpha.-Estradiol 17.beta.-D-Glucopyranoside from Rabbit Urine, and Its Synthesis and Characterization," Biochemistry 8:4299-4304 (Nov. 1969).
Williamson et al., "Metabolism of Intravenously Administered 17.alpha.-[6,7-H]Estradiol-17-Glucoside in Normal Women," Canadian J. Biochem. 50:958-962 (1972).
Rae et al. Clinica Chimica Acta, vol. 176, pp. 71-82, (1988).
Tanouye, The Wall Street Journal, 15 Jun. 95, pp. A1 and A8.
Goodman & Gilman's The Pharmaceutical Basis of Therapeutics, (Eighth Edition), Pergamon Press, pp. 1391, 1394-1395, (1990).
Kight John
Lee Howard C.
LandOfFree
Method for delivering estrogen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for delivering estrogen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for delivering estrogen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1706400